Lyme disease

Textbook of Pediatric Rheumatology

Volumn , Issue , 2011, Pages 579-590

  Huppertz, Hans Iko ^a,b   Dressler, Frank ^c  

^a Childrens' Hospital   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84871292541     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-6581-4.10038-X     Document Type: Chapter

References (247)

1. Steere A.C., Malawista S.E., Snydman D.R., et al. Lyme arthritis. An epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977, 20:7-17.
2. Burgdorfer W., Barbour A.G., Hayes S.F., et al. Lyme disease-a tick-borne spirochetosis?. Science 1982, 216:1317-1319.
3. Steere A.C., Grodzicki R.L., Kornblatt A.N., et al. The spirochetal etiology of Lyme disease. N. Engl. J. Med 1983, 308:733-740.
4. Stanek G., Strle F. Lyme borreliosis. Lancet 2003, 362:1639-1647.
5. Steere A.C. Lyme disease. N. Engl. J. Med 2001, 345:115-125.
6. F. Dressler P. Irigoyen, N. Ilowite, et al., Lyme arthritis, in: S.K. Sood (Ed.), Lyme borreliosis in Europe and North America, 2010, John Wiley, in print.
7. Buchwald A. Ein Fall von diffuser idiopathischer Hautatrophie. Arch. Dermatol. Syph 1883, 10:553.
8. Huppertz H.I., Böhme M., Standaert S.M., et al. Incidence of Lyme borreliosis in the Würzburg region of Germany. Eur. J. Clin. Microbiol. Infect. Dis 1999, 18:697-703.
9. Huppertz H.I., Karch H., Suschke H.J., et al. Lyme arthritis in European children and adolescents. Arthritis Rheum 1995, 38:361-368.
10. Barbour A.G., Hayes S.F. Biology of Borrelia species. Microbiol. Rev 1986, 50:381-400.
11. Fingerle V., Schulte-Spechtel U.C., Ruzic-Sabljic E., et al. Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov. Int. J. Med. Microbiol 2008, 298:279-290.
12. Norman M.U., Moriarty T.J., Dresser A.R., et al. Molecular mechanisms involved in vascular interactions of the Lyme disease pathogen in a living host. PLoS. Pathog 2008, 4:e1000169.
13. Girschick H.J., Huppertz H.I., Rüssmann H., et al. Intracellular persistence of Borrelia burgdorferi in human synovial cells. Rheumatol. Int 1996, 16:125-132.
14. Steere A.C., Glickstein L. Elucidation of Lyme arthritis. Nat. Rev. Immunol 2004, 4:143.
15. Gross D.M., Steere A.C., Huber B.T. T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J. Immunol 1998, 160:1022-1028.
16. Busch D.H., Jassoy C., Brinckmann U., et al. Detection of Borrelia burgdorferi-specific CD8+ cytotoxic T-cells in patients with Lyme arthritis. J. Immunol 1996, 157:3534-3541.
17. Codolo G., Amedei A., Steere A.C., et al. Borrelia burgdorferi NapA-driven Th17 cell inflammation in Lyme arthritis. Arthritis Rheum 2008, 58:3609-3617.
18. Nardelli D.T., Callister S.M., Schell R.F. Lyme arthritis: Current concepts and a change in paradigm. Clin. Vaccine Immunol 2008, 15:21.
19. Feder H.M., Gerber M.A., Krause P.J., et al. Early Lyme disease: a flu-like illness without erythema migrans. Pediatrics 1993, 91:456-459.
20. Christen H.J., Hanefeld F., Eiffert H., et al. Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicentre study with special regard to neuroborreliosis. Acta. Paediatr 1993, 82:1-75.
21. Gerber M.A., Zemel L.S., Shapiro E.D. Lyme arthritis in children: clinical epidemiology and long-term outcomes. Pediatrics 1998, 102:905-908.
22. Huppertz H.I., Michels H. Pattern of joint involvement in children with Lyme arthritis. Br. J. Rheumatol 1996, 35:1016-1018.
23. Huppertz H.I., Münchmeier D., Lieb W. Ocular manifestations in children and adolescents with Lyme arthritis. Br. J. Ophthalmol 1999, 83:1149-1152.
24. Thompson A., Mannix R., Bachur R. Acute pediatric monoarticular arthritis: Distinguishing Lyme arthritis from other etiologies. Pediatrics 2009, 123:959.
25. Sigal L.H., Patella S.J. Lyme arthritis as the incorrect diagnosis in pediatric and adolescent fibromyalgia. Pediatrics 1992, 90:523-528.
26. Szer I.S., Taylor E., Steere A.C. The long-term course of Lyme arthritis in children. N. Engl. J. Med 1991, 325:159-163.
27. Nadal D., Hunziker U.A., Bucher H.U., et al. Infants born to mothers with antibodies against Borrelia burgdorferi at delivery. Eur. J. Pediatr 1989, 148:426-427.
28. Golightly M. Laboratory considerations in the diagnosis and management of Lyme borreliosis. Am. J. Clin. Pathol 1993, 99:168-174.
29. American College of Physicians Guidelines for laboratory evaluation in the diagnosis of Lyme disease. Clinical guideline, part 1. Ann. Intern. Med 1997, 127:1106-1108.
30. Tugwell P., Dennis D.T., Weinstein A., et al. Laboratory evaluation in the diagnosis of Lyme disease. Clinical guideline, part 2. Ann. Intern. Med 1997, 127:1109-1123.
31. Sigal L.H. Pitfalls in the diagnosis and management of Lyme disease. Arthritis Rheum 1998, 41:195-204.
32. Nocton J.J., Dressler F., Rutledge B.J., et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N. Engl. J. Med 1994, 330:229-234.
33. Centers for Disease Control and Prevention (CDC) Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR. Morb. Mortal. Wkly. Rep 1995, 44:590-591.
34. Dressler F., Whalen J.A., Reinhardt B.N., et al. Western blotting in the serodiagnosis of Lyme disease. J. Infect. Dis 1993, 167:392-400.
35. Engstrom S.M., Shoop E., Johnson R.C. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J. Clin. Microbiol 1995, 33:419-427.
36. Hauser U., Lehnert G., Lobentanzer R., et al. Interpretation criteria for standardized Western blots for three European species of. Borrelia burgdorferi sensu lato, J. Clin. Microbiol 1997, 35:1433-1444.
37. Heikkilä T., Huppertz H.I., Seppälä I., et al. Recombinant or peptide antigens in the serology of Lyme arthritis in children. J. Infect. Dis 2003, 187:1888-1894.
38. Steere A.C., McHugh G., Damle N., et al. Prospective study of serologic tests for lyme disease. Clin. Infect. Dis 2008, 47:188-195.
39. Nichol G., Dennis D.T., Steere A.C., et al. Test-treatment strategies for patients suspected of having Lyme disease: a cost-effectiveness analysis. Ann. Intern. Med 1998, 128:37-48.
40. Dressler F., Yoshinari N.H., Steere A.C. The T-cell proliferative assay in the diagnosis of Lyme disease. Ann. Intern. Med 1991, 15:533-539.
41. Huppertz H.I., Mösbauer S., Busch D.H., et al. Lymphoproliferative responses to Borrelia burgdorferi in the diagnosis of Lyme arthritis in children and adolescents. Eur. J. Pediatr 1996, 155:297-302.
42. Huppertz H.I., Bentas W., Haubitz I., et al. Diagnosis of pediatric Lyme arthritis using a clinical score. Eur. J. Pediatr 1998, 157:304-308.
43. Wharton M., Chorba T.L., Vogt R.L., et al. Case definitions for public health surveillance. MMWR. Morb. Mortal. Wkly. Rep 1990, 39:19.
44. Zahid Qureshi M., New D., Zulqarni N.J., et al. Overdiagnosis and overtreatment of Lyme disease in children. Pediatr. Infect. Dis. J 2002, 21:12-14.
45. Wormser G.P., Dattwyler R.J., Shapiro E.D., et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesioisis: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis 2006, 43:1089-1134.
46. Steere A.C., Levin R.E., Molloy P.J., et al. Treatment of Lyme arthritis. Arthritis Rheum 1994, 37:878-888.
47. Bentas W., Karch H., Huppertz H.I. Lyme arthritis in children and adolescents: outcome 12 months after initiation of antibiotic therapy. J. Rheumatol 2000, 27:2025-2030.
48. Wormser G.P., Ramanathan R., Nowakowski J., et al. Duration of antibiotic therapy for early Lyme disease. Ann. Intern. Med 2003, 138:697-704.
49. Kannian P., McHugh G., Johnson B.J.B., et al. Antibody responses to Borrelia burgdorferi in patients with antibiotic-refectory, antibiotic-responsive, or non-antibiotic-treated Lyme arthritis. Arthritis Rheum 2007, 56:4216-4225.
50. Eckman M.H., Steere A.C., Kalish R.A., et al. Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis. N. Engl. J. Med 1997, 337:357-363.
51. Steere A.C., Angelis S.M. Therapy for Lyme arthritis-strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum 2006, 54:3079-3086.
52. American Academy of Pediatrics Committee on Infectious Diseases: Prevention of Lyme disease. Pediatrics 2000, 105:142-147.
53. Hayes E.B., Piesman J. How can we prevent Lyme disease?. N. Engl. J. Med 2003, 348:2424-2430.
54. Warshafsky S., Nowakowski J., Nadelman R.B., et al. Efficacy of antibiotic prophylaxis for prevention of Lyme disease. J. Gen. Intern. Med 1996, 11:329-333.
55. Adams W.V., Rose C.D., Eppes S.C., et al. Cognitive effects of Lyme disease in children: a 4 year followup study. J. Rheumatol 1999, 26:1190-1194.
56. Salazar J.C., Gerber M.A., Goff C.W. Long-term outcome of Lyme disease in children given early treatment. J. Pediatr 1993, 122:591-593.
57. Seltzer E.G., Gerber M.A., Cartter M., et al. Long-term outcomes of persons with Lyme disease. JAMA 2000, 283:609-616.
58. Brescia A.C., Rose C.D., Fawcett P.T. Prolonged synovitis in pediatric Lyme arthritis cannot be predicted by clinical or laboratory parameters. Clin. Rheumatol 2009, 28:591-593.
59. Shadick N.A., Phillips C.B., Logigian E.L., et al. The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann. Intern. Med 1994, 121:560-567.
60. Hassett A.L., Radvanski D.C., Buyske S., et al. Role of psychiatric comorbidity in chronic Lyme disease. Arthritis Rheum 2008, 59:1742-1749.
61. Steere A.C., Malawista S.E., Snydman D.R., et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum. 1977, 20:7-17.
62. Burgdorfer W., Barbour A.G., Hayes S.F., et al. Lyme disease: a tick-borne spirochetosis?. Science 1982, 216:1317-1319.
63. Steere A.C., Grodzicki R.L., Kornblatt A.N., et al. The spirochetal etiology of Lyme disease. N. Engl. J. Med. 1983, 308:733-740.
64. Stanek G., Strle F. Lyme borreliosis. Lancet 2003, 362:1639-1647.
65. Steere A.C. Lyme disease. N. Engl. J. Med. 2001, 345:115-125.
66. Dressler F, Irigoyen P, Ilowite N, et al: Lyme arthritis, in: S.K. Sood (Ed.), Lyme borreliosis in Europe and North America 2010, John Wiley, in print.
67. Buchwald A. Ein Fall von diffuser idiopathischer hautatrophie. Arch. Dermatol. Syph. 1883, 10:553.
68. Afzelius A. Verhandlungen der dermatologischen gesellschaft zu Stockholm. Arch. Dermatol. Syph. 1910, 101:404.
69. Garin C., Bujadoux A. Paralysie par les tiques. J. Med. Lyon. 1922, 71:765.
70. Bannwarth A. Chronische lymphocytäre meningitis, entzündliche polyneuritis und "rheumatismus,". Arch. Psychiatr. Nervenkr. 1941, 113:284.
71. Svartz N. Penicillinbehandling vid dermatitis atrophicans Herxheimer. Nord. Med. 1946, 32:2783.
72. Binder E., Doepfmer R., Hornstein O. Übertragung des erythema chronicum migrans von mensch zu mensch in zwei passagen. Klin. Wochenschr. 1955, 33:27.
73. Steere A.C. Lyme disease: a growing threat to urban populations. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:2378-2383.
74. Bacon R.M., Kugeler K.J., Mead P.S. Surveillance for Lyme disease-United States, 1992-2006. MMWR. Surveill. Summ. 2008, 57:1-9.
75. Ministry of Health of the Republic of Slovenia, Institute of Public Health of the Republic of Slovenia Epidemiological report on communicable diseases in Slovenia Ljubljana 2008, 62-65.
76. Berglund J., Eitrem R., Ornstein K., et al. An epidemiologic study of Lyme disease in Southern Sweden. N. Engl. J. Med. 1995, 333:1319.
77. Huppertz H.I., Böhme M., Standaert S.M., et al. Incidence of Lyme borreliosis in the Würzburg region of Germany. Eur. J. Clin. Microbiol. Infect. Dis. 1999, 18:697-703.
78. Gerber M.A., Shapiro E.D., Burke G.S., et al. Lyme disease in children in southeastern Connecticut. N. Engl. J. Med. 1996, 335:1270-1274.
79. Huppertz H.I., Karch H., Suschke H.J., et al. Lyme arthritis in European children and adolescents. Arthritis Rheum. 1995, 38:361-368.
80. Steere A.C., Dwyer E., Winchester R. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N. Engl. J. Med. 1990, 323:219-223.
81. Iliopoulou B.P., Alroy J., Huber B.T. Persistent arthritis in Borrelia burgdorferi-infected HLA-DR4-positive CD28-negative mice post-antibiotic treatment. Arthritis Rheum. 2008, 58:3892-3901.
82. Fish D. Environmental risk and prevention of Lyme disease. Am. J. Med. 1995, 98:2S-8S.
83. Subak S. Effects of climate on variability in Lyme disease incidence in the Northeastern United States. Am. J. Epidemiol. 2003, 157:531-538.
84. Cimperman J., Maraspin V., Lotric-Furlan S., et al. Concomitant infection with tick-borne encephalitis virus and Borrelia burgdorferi sensu lato in patients with acute meningitis or meningoencephalitis. Infection 1998, 26:160-164.
85. Krause P.J., Telford S.R., Spielman A., et al. Concurrent Lyme disease and babesiosis: evidence for increased severity and duration of disease. JAMA 1996, 275:1657-1660.
86. Nadelman R.B., Horowitz H.W., Hsieh T., et al. Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis. N. Engl. J. Med. 1997, 337:27-30.
87. Barbour A.G., Hayes S.F. Biology of Borrelia species. Microbiol. Rev. 1986, 50:381-400.
88. Richter D., Postic D., Sertour N., et al. Delineation of Borrelia burgdorferi sensu lato species by multilocus sequence analysis and confirmation of the delineation of Borrelia spielmanii sp. nov. Int. J. Syst. Evol. Microbiol. 2006, 56:873-881.
89. Fingerle V., Schulte-Spechtel U.C., Ruzic-Sabljic E., et al. Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov. Int. J. Med. Microbiol. 2008, 298:279-290.
90. Lopes de Carvalho I., Fonseca J.E., Marques J.G., et al. Vasculitis-like syndrome associated with Borrelia lusitaniae infection. Clin. Rheumatol. 2008, 27:1587-1591.
91. Wienecke R., Neubert U., Volkenandt M. Cross immunity among types of Borrelia burgdorferi. Lancet 1993, 342:435.
92. Nowakowski J., Schwartz I., Nadelman R., et al. Culture-confirmed infection and reinfection with Borrelia burgdorferi. Ann. Intern. Med. 1997, 127:130-132.
93. Jones K.L., Seward R.J., Ben-Menachem G., et al. Strong IgG antibody responses to Borrelia burgdorferi glycolipids in patients with Lyme arthritis, a late manifestation of the infection. Clin. Immunol. 2009, 132:93-102.
94. Fraser C.M., Casjens S., Huang W.M., et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 1997, 390:580-586.
95. Anderson JF, Magnarelli LA: Avian and mammalian hosts for spirochete-infected ticks and insects in a Lyme disease focus in Connecticut, in: A.C. Steere, A.C. Malawista, J.E. Craft, et al., (Eds.), First International Symposium on Lyme Disease, New Haven Yale, J. Biol. Med. 57(1984) 638.
96. Coburn J., Magoun L., Bodary S.C., et al. Integrins alpha(v)-beta3 and alpha5beta1 mediate attachment of Lyme disease spirochetes to human cells. Infect. Immun. 1998, 66:1946-1952.
97. Coburn J.C., Leong J.M., Erban J.K. Integrin alpha IIb-beta III mediates binding of the Lyme disease agent Borrelia burgdorferi to human platelets. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:7059-7063.
98. Norman M.U., Moriarty T.J., Dresser A.R., et al. Molecular mechanisms involved in vascular interactions of the Lyme disease pathogen in a living host. PLoS. Pathog. 2008, 4:e1000169.
99. Ma Y., Sturrock A., Weis J.J. Intracellular localization of Borrelia burgdorferi within human endothelial cells. Infect. Immun. 1991, 59:671-678.
100. Klempner M., Noring R., Rogers R.A. Invasion of human skin fibroblasts by the Lyme disease spirochete, Borrelia burgdorferi. J. Infect. Dis. 1993, 167:1074-1081.
101. Girschick H.J., Huppertz H.I., Rüssmann H., et al. Intracellular persistence of Borrelia burgdorferi in human synovial cells. Rheumatol. Int. 1996, 16:125-132.
102. Steere A.C., Glickstein L. Elucidation of Lyme arthritis. Nat. Rev. Immunol. 2004, 4:143.
103. Yang L., Ma Y., Schoenfeld R., et al. Evidence of B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice. Infect. Immun. 1992, 60:3033-3041.
104. Yin Z., Braun J., Neure L., et al. T cell cytokine pattern in the joints of patients with Lyme arthritis and its regulation by cytokines and anticytokines. Arthritis Rheum. 1997, 40:69-79.
105. Gross D.M., Steere A.C., Huber B.T. T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J. Immunol. 1998, 160:1022-1028.
106. Busch D.H., Jassoy C., Brinckmann U., et al. Detection of Borrelia burgdorferi-specific CD8+ cytotoxic T-cells in patients with Lyme arthritis. J. Immunol. 1996, 157:3534-3541.
107. Glatzel A., Entschladen F., Zollner T.M., et al. The responsiveness of human V δ1 γδ-T cells to Borrelia burgdorferi is largely restricted to synovial fluid cells from patients with Lyme arthritis. J. Infect. Dis. 2002, 186:1043-1046.
108. Roessner K., Wolfe J., Shi C., et al. High expression of Fas ligand by synovial fluid-derived γδ-T cells in Lyme arthritis. J. Immunol. 2003, 170:2702-2710.
109. Miller L.C., Isa S., Vannier E., et al. Live Borrelia burgdorferi preferentially activate interleukin-1beta gene expression and protein synthesis over the interleukin-1 receptor antagonist. J. Clin. Invest. 1992, 90:906-912.
110. Habicht G.S., Katona L.I., Benach J.L. Cytokines and the pathogenesis of neuroborreliosis: Borrelia burgdorferi induces glioma cells to secrete interleukin-6. J. Infect. Dis. 1991, 164:568-574.
111. Defosse D.L., Johnson R.C. In vitro and in vivo induction of tumor necrosis factor alpha by Borrelia burgdorferi. Infect. Immun. 1992, 60:1109-1113.
112. Shin J.J., Glickstein L.J., Steere A.C. High levels of inflammatory chemokines and cytokines in joint fluid and synovial tissue throughout the course of antibiotic-refractory Lyme arthritis. Arthritis Rheum. 2007, 56:1325-1335.
113. Pohl-Koppe A., Balashov K.E., Steere A.C., et al. Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection. J. Immunol. 1998, 160:1804-1810.
114. Weigelt W., Schneider T., Lange R. Sequence homology between spirochaete flagellin and human myelin basic protein. Immunol. Today 1992, 13:279-280.
115. Sigal L.H. Cross-reactivity between Borrelia burgdorferi flagellin and a human axonal 64000 molecular weight protein. J. Infect. Dis. 1993, 167:1372-1378.
116. Kalish R., Leong J.M., Steere A.C. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect. Immun. 1993, 61:2774-2779.
117. Kamradt T., Lengl-Janssen B., Strauss A.F., et al. Dominant recognition of a Borrelia burgdorferi outer surface protein A peptide by T helper cells in patients with treatment-resistant Lyme arthritis. Infect. Immun. 1996, 64:1284-1289.
118. Drouin E.E., Glickstein L., Kwok W.W., et al. Human homologues of a Borrelia T cell epitope associated with antibiotic-refractory Lyme arthritis. Mol. Immunol. 2008, 45:180.
119. Gross D.M., Forsthuber T., Tary-Lehmann M., et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 1998, 281:703-706.
120. Steere A.C., Falk B., Drouin E.E., et al. Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum. 2003, 48:534-540.
121. Codolo G., Amedei A., Steere A.C., et al. Borrelia burgdorferi NapA-driven Th17 cell inflammation in Lyme arthritis. Arthritis Rheum. 2008, 58:3609-3617.
122. Nardelli D.T., Callister S.M., Schell R.F. Lyme arthritis: current concepts and a change in paradigm. Clin. Vaccine. Immunol. 2008, 15:21.
123. Malane M.S., Grant-Kels J.M., Feder H.M., et al. Diagnosis of Lyme disease based on dermatologic manifestations. Ann. Intern. Med. 1991, 114:490-498.
124. Feder H.M., Gerber M.A., Krause P.J., et al. Early Lyme disease: a flu-like illness without erythema migrans. Pediatrics 1993, 91:456-459.
125. Pohl-Koppe A., Wilske B., Weiss M., et al. Borrelia lymphocytoma in childhood. Pediatr. Infect. Dis. J. 1998, 17:423-426.
126. Brzonova I., Wollenberg A., Prinz J.C. Acrodermatitis chronica atrophicans affecting all four limbs in an 11-year-old girl. Br. J. Dermatol. 2002, 147:375-378.
127. Christen H.J., Hanefeld F., Eiffert H., et al. Epidemiology and clinical manifestations of Lyme borreliosis in childhood: a prospective multicentre study with special regard to neuroborreliosis. Acta. Paediatr. 1993, 82:1-75.
128. Hansen K., Lebech A.M. The clinical and epidemiologic profile of Lyme neuroborreliosis in Denmark 1985-1990. Brain 1992, 115:399-423.
129. Bloom B.J., Wyckoff P.M., Meissner H.C., et al. Neurocognitive abnormalities in children after classic manifestations of Lyme disease. Pediatr. Infect. Dis. J. 1998, 17:189-196.
130. Shapiro E.E. Guillain-Barré syndrome in a child with serologic evidence of Borrelia burgdorferi infection. Pediatr. Inf. Dis. J. 1998, 17:264-265.
131. Horneff G., Huppertz H.-I., Muller K., et al. Demonstration of Borrelia burgdorferi infection in a child with Guillain Barré syndrome. Eur. J. Pediatr. 1993, 152:810-812.
132. Kan L., Sood S.K., Maytal J. Pseudotumor cerebri in Lyme disease: a case report and review of the literature. Pediatr. Neurol. 1998, 18. 439-431.
133. Scott I.U., Silva-Lepe A., Siatkowski R.M. Chiasmal optic neuritis in Lyme disease. Am. J. Ophthalmol. 1997, 123:136-138.
134. Lock G., Berger G., Grobe H. Neuroborreliosis: progressive encephalomyelitis with cerebral vasculitis. Monatsschr. Kinderheilkd. 1989, 137:101-104.
135. Oksi J., Kalimo H., Marttila R.J., et al. Inflammatory brain changes in Lyme borreliosis: a report on three patients and review of literature. Brain 1996, 119:2143-2154.
136. Chancellor M.B., McGinnis D.E., Shenot P.J., et al. Urinary dysfunction in Lyme disease. J. Urol. 1993, 149:26-30.
137. Huppertz H.I., Karch H. Die Lyme-arthritis im kindesalter: monarthritis des kniegelenks, klinisch nicht unterscheidbar von monarthritiden unbekannter ursache. Monatsschr. Kinderheilkd. 1991, 139:759-764.
138. Hammers-Berggren S., Andersson U., Stiernstedt G. Borrelia arthritis in Swedish children: clinical manifestations in 10 children. Acta. Paediatr. 1992, 81:921-924.
139. Gerber M.A., Zemel L.S., Shapiro E.D. Lyme arthritis in children: clinical epidemiology and long-term outcomes. Pediatrics 1998, 102:905-908.
140. Reimers C.D., de Koning J., Neubert U., et al. Borrelia burgdorferi myositis: report of eight patients. J. Neurol. 1993, 240:278-283.
141. Häupl T., Hahn G., Rittig M., et al. Persistence of Borrelia burgdorferi in ligamentous tissue from a patient with chronic Lyme borreliosis. Arthritis Rheum. 1993, 36:1621-1626.
142. Schnarr S., Wahl A., Jürgens-Saathoff B., et al. Nodular fasciitis, erythema migrans, and oligoarthritis: manifestation of Lyme borreliosis caused by Borrelia afzelii. Scand. J. Rheumatol. 2002, 31:184-186.
143. Huppertz H.I., Michels H. Pattern of joint involvement in children with Lyme arthritis. Br. J. Rheumatol. 1996, 35:1016-1018.
144. Huppertz H.I., Münchmeier D., Lieb W. Ocular manifestations in children and adolescents with Lyme arthritis. Br. J. Ophthalmol. 1999, 83:1149-1152.
145. Thompson A., Mannix R., Bachur R. Acute pediatric monoarticular arthritis: distinguishing Lyme arthritis from other etiologies. Pediatrics 2009, 123:959.
146. Marlovits S., Khanakah G., Striessnig G., et al. Emergence of Lyme arthritis after autologous chondrocyte transplantation. Arthritis Rheum. 2004, 50:259-264.
147. Christofaro R.L., Appel M.H., Gelb R.F., et al. Musculoskeletal manifestations of Lyme disease in children. J. Pediatr. Orthop. 1987, 7:527-530.
148. Hoffmann J.C., Stichtenoth D.O., Zeidler H., et al. Lyme disease in a 74-year-old forest owner with symptoms of dermatomyositis. Arthritis Rheum. 1995, 38:1157-1160.
149. Oksi J., Mertsola J., Reunanen M., et al. Subacute multiple-site osteomyelitis caused by Borrelia burgdorferi. Clin. Infect. Dis. 1994, 19:891-896.
150. Sigal L.H., Patella S.J. Lyme arthritis as the incorrect diagnosis in pediatric and adolescent fibromyalgia. Pediatrics 1992, 90:523-528.
151. Cox J., Krajden M. Cardiovascular manifestations of Lyme disease. Am. Heart. J. 1991, 122:1449-1455.
152. Aaberg T.M. The expanding ophthalmologic spectrum of Lyme disease. Am. J. Ophthalmol. 1989, 107:77-80.
153. Szer I.S., Taylor E., Steere A.C. The long-term course of Lyme arthritis in children. N. Engl. J. Med. 1991, 325:159-163.
154. Edwards K.S., Kanengiser S., Li K.I., et al. Lyme disease presenting as hepatitis and jaundice in a child. Pediatr. Infect. Dis. J. 1990, 9:592-593.
155. Weber K., Bratzke H.J., Neubert U., et al. Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy. Pediatr. Infect. Dis. J. 1988, 7:286-289.
156. Silver H.M. Lyme disease during pregnancy. Infect. Dis. Clin. North. Am. 1997, 11:93-97.
157. Markowitz L.E., Steere A.C., Benach J.L., et al. Lyme disease during pregnancy. JAMA 1986, 255:3394-3396.
158. Nadal D., Hunziker U.A., Bucher H.U., et al. Infants born to mothers with antibodies against Borrelia burgdorferi at delivery. Eur. J. Pediatr. 1989, 148:426-427.
159. Johnston Y.E., Duray P.H., Steere A.C., et al. Spirochetes found in synovial microangiopathic lesions. Am. J. Pathol. 1985, 118:26-34.
160. Snydman D.R., Schenkein D.P., Berardi V.P., et al. Borrelia burgdorferi in joint fluid in chronic Lyme arthritis. Ann. Intern. Med. 1986, 104:798-800.
161. De Koning J., Bosma R.B., Hoogkamp-Korstanje J.A.A. Demonstration of spirochaetes in patients with Lyme disease with a modified silver stain. J. Med. Microbiol. 1987, 23:261-267.
162. Berger B.W., Johnson R.C., Kodner C., et al. Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin. J. Clin. Microbiol. 1992, 30:359-361.
163. Stanek G., Klein J., Bittner R., Glogar D. Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N. Engl. J. Med. 1990, 322:249-252.
164. Lardieri G., Salvi A., Camerini F. Isolation of Borrelia burgdorferi from myocardium. Lancet 1993, 342:490.
165. Frey M., Jaulhac B., Piemont Y., et al. Detection of Borrelia burgdorferi DNA in muscle of patients with chronic myalgia related to Lyme disease. Am. J. Med. 1998, 104:591-594.
166. Eppes S.C., Nelson D.K., Lewis L.L., et al. Characterization of Lyme meningitis and comparison with viral meningitis in children. Pediatrics 1999, 103:1957-1960.
167. Golightly M. Laboratory considerations in the diagnosis and management of Lyme borreliosis. Am. J. Clin. Pathol. 1993, 99:168-174.
168. American College of Physicians Guidelines for laboratory evaluation in the diagnosis of Lyme disease. Clinical guideline, part 1. Ann. Intern. Med. 1997, 127:1106-1108.
169. Tugwell P., Dennis D.T., Weinstein A., et al. Laboratory evaluation in the diagnosis of Lyme disease. Clinical guideline, part 2. Ann. Intern. Med. 1997, 127:1109-1123.
170. Sigal L.H. Pitfalls in the diagnosis and management of Lyme disease. Arthritis Rheum. 1998, 41:195-204.
171. Karlsson M., Hovind-Hougen K., Svenungsson B., et al. Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis. J. Clin. Microbiol. 1990, 28:473-479.
172. Nocton J.J., Dressler F., Rutledge B.J., et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N. Engl. J. Med. 1994, 330:229-234.
173. Carlson D., Hernandez J., Bloom B.J., et al. Lack of Borrelia burgdorferi DNA in synovial fluid samples from patients with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum. 1999, 42:2705-2709.
174. Priem S., Rittig M.G., Kamradt T., et al. An optimized PCR leads to rapid and highly sensitive detection of Borrelia burgdorferi in patients with Lyme borreliosis. J. Clin. Microbiol. 1997, 35:685-690.
175. Huppertz H.I., Schmidt H., Karch H. Detection of Borrelia burgdorferi by nested polymerase chain reaction in cerebrospinal fluid and urine of children with neuroborreliosis. Eur. J. Pediatr. 1993, 152:414-417.
176. Karch H., Huppertz H.I. Repeated detection of Borrelia burgdorferi DNA in synovial fluid of a child with Lyme arthritis. Rheumatol. Int. 1993, 12:227-229.
177. Jaulhac B., Chary-Valckenaere I., Sibilia J., et al. Detection of Borrelia burgdorferi by DNA amplification in synovial tissue samples from patients with Lyme arthritis. Arthritis Rheum. 1996, 39:736-745.
178. Priem S., Burmester G.R., Kamradt T., et al. Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy. Ann. Rheum. Dis. 1998, 57:118-121.
179. Karch H., Huppertz H.I., Böhme M., et al. Demonstration of Borrelia burgdorferi DNA in urine samples from healthy humans whose sera contain B. burgdorferi-specific antibodies. J. Clin. Microbiol. 1994, 32:2312-2314.
180. Brown S.L., Hansen S.L., Langone J.J. Role of serology in the diagnosis of Lyme disease. JAMA 1999, 282:62-66.
181. Centers for Disease Control and Prevention (CDC) Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR. Morb. Mortal. Wkly. Rep. 1995, 44:590-591.
182. Dressler F., Whalen J.A., Reinhardt B.N., et al. Western blotting in the serodiagnosis of Lyme disease. J. Infect. Dis. 1993, 167:392-400.
183. Engstrom S.M., Shoop E., Johnson R.C. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J. Clin. Microbiol. 1995, 33:419-427.
184. Hauser U., Lehnert G., Lobentanzer R., et al. Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato. J. Clin. Microbiol. 1997, 35:1433-1444.
185. Hauser U., Lehnert G., Wilkske B. Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe. J. Clin. Microbiol. 1999, 37:2241-2247.
186. Bacon R.M., Biggerstaff B.J., Schriefer M.E., et al. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant vlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole cell lysates. J. Infect. Dis. 2003, 187:1187-1199.
187. Heikkilä T., Huppertz H.I., Seppälä I., et al. Recombinant or peptide antigens in the serology of Lyme arthritis in children. J. Infect. Dis. 2003, 187:1888-1894.
188. Schulte-Spechtel U., Lehnert G., Liegl G., et al. Significant improvement of the recombinant Borrelia-specific immunoglobulin G immunoblot test by addition of vlsE and a DbpA homologue derived from Borrelia garinii for diagnosis of early neuroborreliosis. J. Clin. Microbiol. 2003, 41:1299-1303.
189. Steere A.C., McHugh G., Damle N., et al. Prospective study of serologic tests for lyme disease. Clin. Infect. Dis. 2008, 47:188-195.
190. Levine D., Tilton R.C., Parry M.F., et al. False positive EBNA IgM and IgG antibody tests for infectious mononucleosis in children. Pediatrics 1994, 94:892-894.
191. Berardi V.P., Weeks K.E., Steere A.C. Serodiagnosis of early Lyme disease: analysis of IgM and IgG antibody responses by using an antibody-capture enzyme immunoassay. J. Infect. Dis. 1988, 158:754-760.
192. Sood S.K., Rubin L.G., Blader M.E., et al. Positive serology for Lyme borreliosis in patients with juvenile rheumatoid arthritis in a Lyme borreliosis endemic area: analysis by immunoblot. J. Rheumatol. 1993, 20:739-741.
193. Saulsbury F.T., Katzmann J.A. Prevalence of antibody to Borrelia burgdorferi in children with juvenile rheumatoid arthritis. J. Rheumatol. 1990, 17:1193-1194.
194. Weiss N.L., Sadock V.A., Sigel L.H., et al. False positive seroreactivity to Borrelia burgdorferi in systemic lupus erythematosus: value of immunoblot analysis. Lupus 1995, 4:131-137.
195. Rose C.D., Fawcett P.T., Gibney K.M., et al. Residual serologic reactivity in children with resolved Lyme arthritis. J. Rheumatol. 1996, 23:367-369.
196. Nichol G., Dennis D.T., Steere A.C., et al. Test-treatment strategies for patients suspected of having Lyme disease: a cost-effectiveness analysis. Ann. Intern. Med. 1998, 128:37-48.
197. Dressler F., Yoshinari N.H., Steere A.C. The T-cell proliferative assay in the diagnosis of Lyme disease. Ann. Intern. Med. 1991, 15:533-539.
198. Zoschke D.C., Skemp A.A., Defosse D.L. Lymphoproliferative responses to B. burgdorferi in Lyme disease. Ann. Intern. Med. 1991, 114:285-289.
199. Huppertz H.I., Mösbauer S., Busch D.H., et al. Lymphoproliferative responses to Borrelia burgdorferi in the diagnosis of Lyme arthritis in children and adolescents. Eur. J. Pediatr. 1996, 155:297-302.
200. Holl-Wieden A., Suerbaum S., Girschick H.J. Seronegative Lyme arthritis. Rheumatol. Int. 2007, 27:1091.
201. Rutkowski S., Busch D.H., Huppertz H.I. Lymphocyte proliferation assay in response to Borrelia burgdorferi in patients with Lyme arthritis: analysis of lymphocyte subsets. Rheumatol. Int. 1997, 17:151-158.
202. Huppertz H.I., Bentas W., Haubitz I., et al. Diagnosis of pediatric Lyme arthritis using a clinical score. Eur. J. Pediatr. 1998, 157:304-308.
203. Wharton M., Chorba T.L., Vogt R.L., et al. Case definitions for public health surveillance. MMWR. Morb. Mortal. Wkly. Rep. 1990, 39:19.
204. Böhme M., Schweneke S., Fuchs E., et al. Screening of blood donors and recipients for Borrelia burgdorferi antibodies: no evidence of B. burgdorferi infection transmitted by transfusion. Infusionstherapie. 1992, 19:204-207.
205. Zahid Qureshi M., New D., Zulqarni N.J., et al. Overdiagnosis and overtreatment of Lyme disease in children. Pediatr. Infect. Dis. J. 2002, 21:12-14.
206. Huppertz H.I., Karch H., Heesemann J. Diagnostic value of synovial fluid analysis in children with reactive arthritis. Rheumatol. Int. 1995, 15:167-170.
207. Kaiser R., Rauer S. Analysis of the intrathecal immune response in neuroborreliosis to a sonicate antigen and three recombinant antigens of Borrelia burgdorferi sensu stricto. Eur. J. Clin. Microbiol. Infect. Dis. 1998, 17:159-166.
208. Wormser G.P., Dattwyler R.J., Shapiro E.D., et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesioisis: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 2006, 43:1089-1134.
209. Dattwyler R.J., Volkman D.J., Conaty S.M., et al. Amoxicillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis. Lancet 1990, 336:1404-1406.
210. Dattwyler R.J., Halperin J.J., Volkman D.J., et al. Treatment of late Lyme borreliosis-randomised comparison of ceftriaxone and penicillin. Lancet 1988, 1:1191-1194.
211. Weber K., Preac-Mursic V., Wilske B., et al. A randomized trial of ceftriaxone versus oral penicillin for the treatment of early European Lyme borreliosis. Infection 1990, 18:91-96.
212. Pfister H.W., Preac-Mursic V., Wilske B., et al. Cefotaxime versus penicillin G for acute neurologic manifestations in Lyme borreliosis: a prospective randomized study. Arch. Neurol. 1989, 46:1190-1194.
213. Müllegger R.R., Millner M.M., Stanek G., et al. Penicillin G sodium and ceftriaxone in the treatment of neuroborreliosis in children: a prospective study. Infection 1991, 19:279-283.
214. Massarotti E.M., Luger S.W., Rahn D.W., et al. Treatment of early Lyme disease. Am. J. Med. 1992, 92:396-403.
215. Nadelman R.B., Luger S.W., Frank E., et al. Comparison of cefuroxime and doxycycline in the treatment of early Lyme disease. Ann. Intern. Med. 1992, 117:273-280.
216. Eppes S.C., Childs J.A. Comparative study of cefuroxime axetil versus amoxicillin in children with early Lyme disease. Pediatrics 2002, 109:1173-1177.
217. Hansen K., Hovmark A., Lebeque A.M., et al. Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans. Acta. Derm. Venerol. 1992, 72:297-300.
218. Weber K., Wilske B., Preac-Mursic V., et al. Azithromycin versus penicillin V for the treatment of early Lyme borreliosis. Infection 1993, 21:367-372.
219. Strle F., Preac-Mursic V., Cimperman J., et al. Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiologic findings. Infection 1993, 21:83-88.
220. Luft B.J., Dattwyler R.J., Johnson R.C., et al. Azithromycin compared with amoxicillin in the treatment of erythema migrans: a double-blind, randomized, controlled trial. Ann. Intern. Med. 1996, 124:785-791.
221. Steere A.C., Levin R.E., Molloy P.J., et al. Treatment of Lyme arthritis. Arthritis Rheum. 1994, 37:878-888.
222. Bentas W., Karch H., Huppertz H.I. Lyme arthritis in children and adolescents: outcome 12 months after initiation of antibiotic therapy. J. Rheumatol. 2000, 27:2025-2030.
223. Wormser G.P., Ramanathan R., Nowakowski J., et al. Duration of antibiotic therapy for early Lyme disease. Ann. Intern. Med. 2003, 138:697-704.
224. Thorstrand C., Belfrage E., Bennet R., et al. Successful treatment of neuroborreliosis with ten day regimens. Pediatr. Infect. Dis. J. 2002, 21:1142-1145.
225. Kannian P., McHugh G., Johnson B.J.B., et al. Antibody responses to Borrelia burgdorferi in patients with antibiotic-refectory, antibiotic-responsive, or non-antibiotic-treated Lyme arthritis. Arthritis Rheum. 2007, 56:4216-4225.
226. Eckman M.H., Steere A.C., Kalish R.A., et al. Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis. N. Engl. J. Med. 1997, 337:357-363.
227. Ljostad U., Skogvall E., Eikeland R., et al. Oral doxycycline versus intravenous ceftriaxone for European neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol. 2008, 7:690-695.
228. Gasser R., Wendelin I., Reisinger E., et al. Roxithromycin in the treatment of Lyme disease: update and perspectives. Infection 1995, 23:S39-S43.
229. Schoen R.T., Aversa J.M., Rahn D.W., et al. Treatment of refractory chronic Lyme arthritis with arthroscopic synovectomy. Arthritis Rheum. 1991, 34:1056-1060.
230. Steere A.C., Angelis S.M. Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum. 2006, 54:3079-3086.
231. American Academy of Pediatrics, Committee on Infectious Diseases: Prevention of Lyme disease. Pediatrics 2000, 105:142-147.
232. Hayes E.B., Piesman J. How can we prevent Lyme disease?. N. Engl. J. Med. 2003, 348:2424-2430.
233. Crippa M., Rais O., Gern L. Investigations on the mode and dynamics of transmission and infectivity of Borrelia burgdorferi sensu stricto and Borrelia afzelii in Ixodes ricinus ticks. Vector. Borne. Zoonotic. Dis. 2002, 2:3-9.
234. Nadelman R.B., Nowakowski J., Fish D., et al. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N. Engl. J. Med. 2001, 345:79-84.
235. Warshafsky S., Nowakowski J., Nadelman R.B., et al. Efficacy of antibiotic prophylaxis for prevention of Lyme disease. J. Gen. Intern. Med. 1996, 11:329-333.
236. Steere A.C., Sikand V.K., Meurice F., et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N. Engl. J. Med. 1998, 339:209-215.
237. Sigal L.H., Zahradnik J.M., Lavin P., et al. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. N. Engl. J. Med. 1998, 339:216-222.
238. Feder H.M., Beran J., van Hoecke C., et al. Immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against Lyme disease in children. J. Pediatr. 1999, 135:575-579.
239. Center for Disease Control and Prevention Recommendations for the use of Lyme disease vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recomm. Rep. 1999, 48:1-17. 21-25.
240. Ball R., Shadowmy S.V., Meyer A., et al. HLA type and immune response to Borrelia burgdorferi outer surface protein A in people in whom arthritis developed after Lyme disease vaccination. Arthritis Rheum. 2009, 60:1179-1186.
241. Adams W.V., Rose C.D., Eppes S.C., et al. Cognitive effects of Lyme disease in children: a 4 year followup study. J. Rheumatol. 1999, 26:1190-1194.
242. Salazar J.C., Gerber M.A., Goff C.W. Long-term outcome of Lyme disease in children given early treatment. J. Pediatr. 1993, 122:591-593.
243. Seltzer E.G., Gerber M.A., Cartter M., et al. Long-term outcomes of persons with Lyme disease. JAMA 2000, 283:609-616.
244. Brescia A.C., Rose C.D., Fawcett P.T. Prolonged synovitis in pediatric Lyme arthritis cannot be predicted by clinical or laboratory parameters. Clin. Rheumatol. 2009, 28:591-593.
245. Adams W.V., Rose C.D., Eppes S.C., et al. Cognitive effects of Lyme disease in children. Pediatrics 1994, 94:185-189.
246. Shadick N.A., Phillips C.B., Logigian E.L., et al. The long-term clinical outcomes of Lyme disease: a population-based retrospective cohort study. Ann. Intern. Med. 1994, 121:560-567.
247. Hassett A.L., Radvanski D.C., Buyske S., et al. Role of psychiatric comorbidity in chronic Lyme disease. Arthritis Rheum. 2008, 59:1742-1749.